Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCP with Collagen Membrane vs Enamel Matrix Proteins for Furcation Defects
NCT04059458Phase 4Terminated
- Sponsor
- University of Oslo
- Start
- Oct 2019
- Primary completion
- Nov 2023
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of enamel matrix derivative in Furcation defect, sponsored by University of Oslo. Started Oct 2019; status: terminated.
02
Drugs
enamel matrix derivative
03
Conditions
Furcation defect
Beyond the preview
Go deeper on NCT04059458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059458.